Unlike the clustering and factor analysis approaches of [ 2, 5, 27, 28], we allow the information content of a model signature to be evaluated against its expression pattern across a large panel of tumour samples, thus allowing the consistency and relevance of the model in the different cellular context to be established before estimating module activity.
In the formation control loop, the controller module is a distributed non-linear model predictive controller and the estimator module fuses local estimates of the target state, obtained by a particle filter at each robot.
To estimate the module performance, we used conventional membrane area-based power density (Warea), as well as proposed and used a novel estimable parameter, power output per module volume (Wvol.), which promises to be useful when designing full-scale PRO plants.
Even the well qualified modules are found to fail or degrade more than their expected levels when exposed to the outdoor conditions, indicating that these tests are not adequately addressing the real outdoor conditions and are not sufficient to estimate the module lifetime.
More precisely, the architecture of the baseband processor integrates the following modules: MIMAX channel estimation: This module estimates the n T n R MIMO channel.
The results presented in Fig. 10 are FFO estimates of module II based on single PSS symbol correlation and CP-based estimator.
While simulations using the developed model estimated a module efficiency of ∼3.23% and an annual electrical energy generation of 448 kWh/m2, the fabricated module with a cell width of ∼18 mm exhibited an efficiency of ∼3.19%; the design is also conducive for practical manufacturing and thermal reliability.
However, if integer CFO is present in the received signal, it will affect the estimates of module I. So, module II which is a joint timing, integer CFO, and SID estimator is used in nullifying the CFO effect.
In summary, this work has applied a novel strategy for estimating pathway module activity levels in clinical tumours.
Thus, estimating pathway module activity levels and considering models of combined pathway activation to delineate novel prognostic subtypes may hold promise as a general technique for proposing novel and more effective combinational therapies.
